|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.46 USD | -0.48% |
|
+11.28% | +85.13% |
| 07-13 | Stifel Nicolaus Initiates Coverage on Candel Therapeutics With Buy Rating, $22 Price Target | MT |
| 06-30 | Candel Therapeutics Stock Gains on Launch of Phase 3 Trial for Lung-Cancer Drug | DJ |
| Market Cap | 766M 664M 619M 569M 1.07B 72.88B 1.09B 7.27B 2.85B 36.46B 2.88B 2.82B 121B | P/E 2026 * |
-11.6x | P/E 2027 * | -14.7x |
|---|---|---|---|---|---|
| Enterprise Value | 766M 664M 619M 569M 1.07B 72.88B 1.09B 7.27B 2.85B 36.46B 2.88B 2.82B 121B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 17.9x |
| Free-Float |
84.33% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Candel Therapeutics, Inc.
| 1 day | -0.48% | ||
| 1 week | +11.28% | ||
| Current month | +4.50% | ||
| 1 month | +6.41% | ||
| 3 months | +36.38% | ||
| 6 months | +97.73% | ||
| Current year | +85.13% |
| 1 week | 9.51 |  | 10.82 |
| 1 month | 9.16 | | 10.82 |
| Current year | 4.44 | | 11.36 |
| 1 year | 4.35 | | 11.36 |
| 3 years | 0.66 | | 14.6 |
| 5 years | 0.66 | | 14.78 |
| 10 years | 0.66 | | 14.78 |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul-Peter Tak
CEO | Chief Executive Officer | 66 | 2020-08-31 |
Charles Schoch
DFI | Director of Finance/CFO | 41 | 2024-01-11 |
William Nichols
CTO | Chief Tech/Sci/R&D Officer | 57 | 2022-09-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Edward Benz
BRD | Director/Board Member | 80 | 2017-08-31 |
Paul-Peter Tak
BRD | Director/Board Member | 66 | 2020-08-31 |
Paul Manning
CHM | Chairman | 70 | 2021-07-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/6/26 | Free | Executive/Senior Manager | 285,000 | 0.3890% | ||
| 6/30/26 | Free | Director | 381 | 0.0005% | ||
| 6/30/26 | Free | Director | 1,331 | 0.0018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.48% | +11.28% | +69.53% | +896.19% | 766M | |
| +0.90% | -2.33% | +0.68% | +13.87% | 48.57B | |
| +1.98% | +9.05% | +413.94% | +532.17% | 41.95B | |
| +3.44% | -4.65% | +28.34% | +8.81% | 38.85B | |
| +1.40% | +0.10% | +6.61% | +61.93% | 37.24B | |
| +2.42% | +5.72% | +12.38% | +44.79% | 30.67B | |
| -0.16% | -3.11% | - | - | 16.1B | |
| +2.20% | +0.48% | +34.71% | +127.15% | 16.41B | |
| +1.25% | +1.52% | +4.62% | +18.26% | 13.97B | |
| +4.25% | -8.23% | -1.49% | -35.46% | 12.62B | |
| Average | +1.72% | +0.43% | +63.26% | +185.30% | 25.71B | |
| Weighted average by Cap. | +1.91% | -0.08% | +82.11% | +122.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 42.84M 37.1M 34.58M 31.81M 60.05M 4.07B 60.72M 406M 160M 2.04B 161M 157M 6.75B |
| Net income | -61.55M -53.3M -49.69M -45.7M -86.28M -5.85B -87.24M -584M -229M -2.93B -231M -226M -9.7B | -54.13M -46.88M -43.7M -40.19M -75.87M -5.15B -76.72M -514M -202M -2.58B -203M -199M -8.53B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-05 | US$10.46 | -0.48% | 750,662 |
| 26-08-04 | US$10.51 | +4.37% | 1,072,773 |
| 26-08-03 | US$10.07 | +0.60% | 879,390 |
| 26-07-31 | US$10.01 | +1.42% | 1,117,505 |
| 26-07-30 | US$9.870 | +5.00% | 875,603 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CADL Stock
Select your edition
All financial news and data tailored to specific country editions
